Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer4 Nov 2026

962 Immune related hepatitis is associated with improved survival in patients with melanoma and liver metastases

Michael Dougan¹
Xue Bai¹
Aleigha Lawless²
Tatyana Sharova²
Leyre Zubiri³
Abigail Lee⁴
Ben Ouyang⁵
Sonia Cohen⁶
Anastasios Karneris¹
Tino Karakousis¹
Hannah R Burnette⁷
Rohan K Desai⁸

5 more authors

Douglas B Johnson⁹
Kerry L Reynolds¹
Ryan J Sullivan¹
Genevieve M Boland¹
Steven M Blum¹

9 affiliations

¹Massachusetts General Hospital, Boston, MA, USA
²1Massachusetts General Hospital, Boston, MA, USA
³2 Harvard Medical School, Boston, Massachusetts, USA
⁴senior house officer
⁵1 Medical Oncology, Mass General Cancer Center, Boston, Massachusetts, USA
⁶Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
⁷Vanderbilt Ingram Cancer Center, Nashville, TN, USA
⁸Vanderbilt University School of Medicine, Nashville, TN, USA
⁹Vanderbilt University Medical Center, Nashville, TN, USA

Open at source PDF DOI Cite

Peripheral immune-inflammatory markers associated with intracranial progression-free survival after Gamma Knife radiosurgery in patients with non-small cell lung cancer brain metastases: a retrospective cohort study.
Wei Han, Hualin Wei, Ting Zeng +3
Frontiers in medicine13 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved survival in patients with FIGO stage IIB-IIIC cervical cancer: a single-center retrospective study.
Qin Zhang, Lin Li, Xiuying Li +1
Frontiers in oncology7 Oct 2026Peer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
WBRT Plus SIB in Patients with Brain Metastases: Association with Longer Overall Survival and Safety Outcomes in a Single-Center Retrospective Analysis
Zibo Tang, Guixiang Liao, Juan Fan
Cancers15 Oct 2026Peer-reviewedCC BY 4.0OncologyCrossref
Immunizing small cell lung cancer mice with isoaspartylated Elavl4 after chemotherapy mimics improved survival of anti-ELAVL4 antibody-positive small cell lung cancer patients
D. A. Velarde, J. A. Valdes, H. Lee +10
bioRxiv31 Aug 2026PreprintAll rights reservedFull textOncologybioRxiv
Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy
D. Bukovec, M. Gjorgjievska, S. Kocevska +5
medRxiv15 Sep 2026PreprintAll rights reservedFull textOncologymedRxiv

Cite

BibTeX RIS

BibTeX

@article{dougan2026immune,
  title = {{962 Immune related hepatitis is associated with improved survival in patients with melanoma and liver metastases}},
  author = {Michael Dougan and Xue Bai and Aleigha Lawless and Tatyana Sharova and Leyre Zubiri and Abigail Lee and Ben Ouyang and Sonia Cohen and Anastasios Karneris and Tino Karakousis and Hannah R Burnette and Rohan K Desai and Douglas B Johnson and Kerry L Reynolds and Ryan J Sullivan and Genevieve M Boland and Steven M Blum},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0962},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0962},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - 962 Immune related hepatitis is associated with improved survival in patients with melanoma and liver metastases
AU  - Michael Dougan
AU  - Xue Bai
AU  - Aleigha Lawless
AU  - Tatyana Sharova
AU  - Leyre Zubiri
AU  - Abigail Lee
AU  - Ben Ouyang
AU  - Sonia Cohen
AU  - Anastasios Karneris
AU  - Tino Karakousis
AU  - Hannah R Burnette
AU  - Rohan K Desai
AU  - Douglas B Johnson
AU  - Kerry L Reynolds
AU  - Ryan J Sullivan
AU  - Genevieve M Boland
AU  - Steven M Blum
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0962
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0962
SN  - 2051-1426
ER  -

Related

Cite